These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3260776)

  • 41. Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide.
    Boulanger C; Schini VB; Moncada S; Vanhoutte PM
    Br J Pharmacol; 1990 Sep; 101(1):152-6. PubMed ID: 2178013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glucose elevations alter bradykinin-stimulated intracellular calcium accumulation in cultured endothelial cells.
    Pieper GM; Dondlinger L
    Cardiovasc Res; 1997 Apr; 34(1):169-78. PubMed ID: 9217887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide.
    Myers PR; Minor RL; Guerra R; Bates JN; Harrison DG
    Nature; 1990 May; 345(6271):161-3. PubMed ID: 2110626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.
    Gryglewski RJ; Palmer RM; Moncada S
    Nature; 1986 Apr 3-9; 320(6061):454-6. PubMed ID: 3007998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterogeneous populations of K+ channels mediate EDRF release to flow but not agonists in rabbit aorta.
    Hutcheson IR; Griffith TM
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H590-6. PubMed ID: 7511348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
    Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Recent advances in EDRF research].
    Shikano K
    Nihon Rinsho; 1992 Jun; 50(6):1430-6. PubMed ID: 1518161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled.
    de Nucci G; Gryglewski RJ; Warner TD; Vane JR
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2334-8. PubMed ID: 2832851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous measurement of endothelium-derived relaxing factor by bioassay and guanylate cyclase stimulation.
    Kondo K; Mitchell JA; de Nucci G; Vane JR
    Br J Pharmacol; 1989 Oct; 98(2):630-6. PubMed ID: 2573403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypertension alters the endothelial-dependent biphasic response of bradykinin in isolated Microminipig basilar artery.
    Zahorul Islam M; Kawaguchi H; Miura N; Miyoshi N; Yamazaki-Himeno E; Shiraishi M; Miyamoto A; Tanimoto A
    Microvasc Res; 2017 Nov; 114():52-57. PubMed ID: 28587989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of cultured cells to study the relationship between arachidonic acid and endothelium-derived relaxing factor.
    Johns RA; Izzo NJ; Milner PJ; Loeb AL; Peach MJ
    Am J Med Sci; 1988 Apr; 295(4):287-92. PubMed ID: 2834949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of bovine endothelial thromboxane receptors triggers release of prostacyclin but not EDRF.
    Clesham G; Parsaee H; Joseph S; McEwan JR; MacDermot J
    Cardiovasc Res; 1992 May; 26(5):513-7. PubMed ID: 1446322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelial cells have a particulate enzyme system responsible for EDRF formation: measurement by vascular relaxation.
    Mitchell JA; Förstermann U; Warner TD; Pollock JS; Schmidt HH; Heller M; Murad F
    Biochem Biophys Res Commun; 1991 May; 176(3):1417-23. PubMed ID: 1710114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins.
    Chin JH; Azhar S; Hoffman BB
    J Clin Invest; 1992 Jan; 89(1):10-8. PubMed ID: 1309534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abluminal release and asymmetrical response of the rabbit arterial wall to endothelium-derived relaxing factor.
    Bassenge E; Busse R; Pohl U
    Circ Res; 1987 Nov; 61(5 Pt 2):II68-73. PubMed ID: 3117407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EDRF: nitrosylated compound or authentic nitric oxide.
    Bates JN; Harrison DG; Myers PR; Minor RL
    Basic Res Cardiol; 1991; 86 Suppl 2():17-26. PubMed ID: 1953608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of endothelium-derived relaxing factor activity in the coronary and renal arteries of the pig.
    Christie MI; Lewis MJ
    Eur J Pharmacol; 1991 Sep; 202(2):143-9. PubMed ID: 1724965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
    Kuhn M; Otten A; Frölich JC; Förstermann U
    J Pharmacol Exp Ther; 1991 Feb; 256(2):677-82. PubMed ID: 1847208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Similar responsiveness of smooth muscle of the canine basilar artery to EDRF and nitric oxide.
    Katusic ZS; Marshall JJ; Kontos HA; Vanhoutte PM
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1235-9. PubMed ID: 2552840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of oxidative metabolism on endothelium-dependent vascular relaxation of isolated vessels.
    Cappelli-Bigazzi M; Battaglia C; Pannain S; Chiariello M; Ambrosio G
    J Mol Cell Cardiol; 1997 Mar; 29(3):871-9. PubMed ID: 9152848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.